Literature DB >> 6237616

Neutrophil chemotaxis in patients with acne receiving oral tetracycline therapy.

N B Esterly, J S Koransky, N L Furey, M Trevisan.   

Abstract

The effect of zymosan-activated serum samples, obtained from patients with acne who were receiving oral tetracycline hydrochloride therapy, on the chemotaxis and random migration of autologous polymorphonuclear leukocytes (PMNLs) and PMNLs from control donors was assayed in a Sykes-Moore chamber by a double-filter technique. Cells incubated with autologous serum specimens from these patients demonstrated significant suppression of both random migration and chemotaxis, with the greatest effect seen at a dosage of 1 g daily and a significant effect found at all dosage levels. When zymosan-activated serum samples from these patients were assayed with control donor PMNLs, similar inhibitory effects were shown. Assays of control sera and PMNLs from tetracycline-treated patients with acne showed the least degree of inhibition of chemotaxis. Although the mechanism of action is unclear, tetracycline appears to have a direct effect on neutrophil movement.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6237616

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  22 in total

Review 1.  Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?

Authors:  M T Labro
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

Review 2.  Tropical sprue.

Authors:  Samir Kumar Nath
Journal:  Curr Gastroenterol Rep       Date:  2005-10

3.  Tetracycline suppresses ATP gamma S-induced CXCL8 and CXCL1 production by the human dermal microvascular endothelial cell-1 (HMEC-1) cell line and primary human dermal microvascular endothelial cells.

Authors:  Anna Bender; Tamar Zapolanski; Shannon Watkins; Ava Khosraviani; Kristina Seiffert; Wanhong Ding; John A Wagner; Richard D Granstein
Journal:  Exp Dermatol       Date:  2008-03-13       Impact factor: 3.960

Review 4.  Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature.

Authors:  Michael O Griffin; Eduardo Fricovsky; Guillermo Ceballos; Francisco Villarreal
Journal:  Am J Physiol Cell Physiol       Date:  2010-06-30       Impact factor: 4.249

Review 5.  The post-cardiac arrest syndrome: A case for lung-brain coupling and opportunities for neuroprotection.

Authors:  Nguyen Mai; Kathleen Miller-Rhodes; Sara Knowlden; Marc W Halterman
Journal:  J Cereb Blood Flow Metab       Date:  2019-03-13       Impact factor: 6.200

6.  Microfluidic arenas for war games between neutrophils and microbes.

Authors:  Felix Ellett; Fatemeh Jalali; Anika L Marand; Julianne Jorgensen; Baris R Mutlu; Jarone Lee; Adam B Raff; Daniel Irimia
Journal:  Lab Chip       Date:  2019-03-27       Impact factor: 6.799

Review 7.  Minocycline: far beyond an antibiotic.

Authors:  N Garrido-Mesa; A Zarzuelo; J Gálvez
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

8.  Tetracyclines modulate protease-activated receptor 2-mediated proinflammatory reactions in epidermal keratinocytes.

Authors:  Chika Ishikawa; Tatsuya Tsuda; Hiroe Konishi; Noboru Nakagawa; Kiyofumi Yamanishi
Journal:  Antimicrob Agents Chemother       Date:  2009-03-02       Impact factor: 5.191

Review 9.  Tetracycline repurposing in neurodegeneration: focus on Parkinson's disease.

Authors:  Mariza Bortolanza; Glauce C Nascimento; Sergio B Socias; Diego Ploper; Rosana N Chehín; Rita Raisman-Vozari; Elaine Del-Bel
Journal:  J Neural Transm (Vienna)       Date:  2018-08-14       Impact factor: 3.575

Review 10.  Acne. A review of optimum treatment.

Authors:  N L Sykes; G F Webster
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.